Ophtec Unfazed By FDA Panel Limitations On Phakic IOL Patient Group
This article was originally published in The Gray Sheet
Executive Summary
Ophtec expects FDA to approve its Artisan phakic intraocular lens in the next six months with less restrictive labeling than recommended by the Ophthalmic Devices Panel Feb. 5